Skip to content

Examination of 1 week continuous ingestion of drink containing plant extract. A-18001

Examination of 1 week continuous ingestion of drink containing plant extract. A-18001 - Examination of 1 week continuous ingestion of drink containing plant extract. A-18001

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030880
Enrollment
24
Registered
2018-01-22
Start date
2018-01-23
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Drink containing plant extract (1 week continuous ingestion)-&gt
placebo drink not containing plant extract (1 week continuous ingestion) Placebo drink not containing plant extract (1 week continuous ingestion)-&gt
Drink containing plant extract (1 week continuous ingestion)

Sponsors

Kao Corporation
Lead Sponsor
SOUKEN Co., Ltd.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1.Person whose body math indexes are less than 18.5 or more than 25.0. 2.Person whose diastolic blood pressures are more than 90mmHg and systolic ones are more than 140mmHg. 3.Person who has severe allergic disease as rhinitis, atopicdermatitis. 4.Person who is pregnant, lactating or planned to become pregnant during the test period. 5.Patient with vascular function disorder. 6.Person who has problems with electrocardiogram test such as arrhythmia. 7.Person who takes medicine. 8.Person who regularly goes to hospital or went to the medical institution within a month. 9.Current smoker. 10.Person who plans to participate in the other clinical studies. 11.Person who is judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Skin temperature before and after 1day drink ingestion.

Secondary

MeasureTime frame
Peripheral blood flow and subjective evaluation.

Countries

Japan

Contacts

Public ContactNorio Shimizu

Kao Corporation R&D-Skin Care Products Research

shimizu.norio@kao.com+81-465-35-3175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026